Back
WisdomTree Global ex-US Quality Growth Fund Vs. Regeneron Pharmaceuticals, Inc. Industry Stock Comparison
Buy
57
DNL
WisdomTree Global ex-US Quality Growth Fund
Last Price:
$41.44
Seasonality Move:
1.75%
Buy
60
REGN
Regeneron Pharmaceuticals, Inc.
Last Price:
$784.62
Seasonality Move:
12.13%
Buy
57
WisdomTree Global ex-US Quality Growth Fund (DNL)
is a Buy
Is WisdomTree Global ex-US Quality Growth Fund a Buy, Sell or Hold?
-
The current WisdomTree Global ex-US Quality Growth Fund [DNL] share price is $41.50. The Score for DNL is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
DNL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
60
Regeneron Pharmaceuticals, Inc. (REGN)
is a Buy
Is Regeneron Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Regeneron Pharmaceuticals, Inc. [REGN] share price is $784.97. The Score for REGN is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
REGN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DNL Stock Price Chart
What is WisdomTree Global ex-US Quality Growth Fund's stock price today?
-
The WisdomTree Global ex-US Quality Growth Fund share price today is $41.50Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DNL is experiencing buying pressure, which is a positive indicator for future bullish movement.
REGN Stock Price Chart
What is Regeneron Pharmaceuticals, Inc.'s stock price today?
-
The Regeneron Pharmaceuticals, Inc. share price today is $784.97Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REGN is experiencing slight buying pressure.
DNL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.18 | Buy |
| Relative Strength Index (14 RSI): | 58.26 | Buy |
| Chaikin Money Flow: | 16655 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.09 - 41.37) | Buy |
| Bollinger Bands (100): | (39.59 - 41.25) | Buy |
REGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 212.63 | Buy |
| Relative Strength Index (14 RSI): | 67.49 | Buy |
| Chaikin Money Flow: | 125325 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (724.62 - 777.16) | Buy |
| Bollinger Bands (100): | (556.48 - 712.42) | Buy |
DNL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.09 | Buy |
| 20-day SMA: | 41 | Buy |
| 50-day SMA: | 40.88 | Buy |
| 200-day SMA: | 39.22 | Buy |
| 8-day EMA: | 41.22 | Buy |
| 20-day EMA: | 41.01 | Buy |
| 50-day EMA: | 40.79 | Buy |
| 200-day EMA: | 39.67 | Buy |
REGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 768.25 | Buy |
| 20-day SMA: | 747.3 | Buy |
| 50-day SMA: | 695.26 | Buy |
| 200-day SMA: | 602.28 | Buy |
| 8-day EMA: | 643.63 | Buy |
| 20-day EMA: | 389.89 | Buy |
| 50-day EMA: | 188.67 | Buy |
| 200-day EMA: | 52.17 | Buy |
WisdomTree Global ex-US Quality Growth Fund Earnings Growth & DNL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Regeneron Pharmaceuticals, Inc. Earnings Growth & REGN Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $3.81 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.74 per share, and an increase next year of $1.14 per share.
WisdomTree Global ex-US Quality Growth Fund Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Regeneron Pharmaceuticals, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||